Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qingwen baidu san is a traditional Chinese medicine (TCM) herbal formula primarily utilized in veterinary medicine for its potent heat-clearing, detoxifying, and blood-cooling properties. The formulation is a complex mixture of multiple herbs, including Gypsum Fibrosum, Rehmanniae Radix, and Scutellariae Radix, designed to treat severe febrile diseases and systemic inflammatory conditions in livestock and poultry. It is commonly manufactured by Shijiazhuang Yinuo Animal Pharmaceutical and administered as an oral powder or feed additive. The drug is indicated for the management of high fever, toxemia, and various viral infections (such as swine fever or avian influenza symptoms) by modulating the immune response and reducing inflammatory cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qingwen baidu san.